25 Top Ranked Socially Responsible Dividend Stocks
By The Online Investor Staff, updated Fri., Mar. 29, 2:03 AM
This Slide: #2 of 25 |
#24. AbbVie Inc (NYSE:ABBV) — 3.44% Yield
AbbVie is a research-based biopharmaceutical company. Co. operates as a single business segment dedicated to the research and development, manufacturing, commercialization and sale of medicines and therapies. Co.'s products include: immunology products such as Humira, Skyrizi, and Rinvoq; oncology products such as Imbruvica and Venclexta/Venclyxto; aesthetics products such as Botox Cosmetic and The Juvederm Collection of Fillers; neuroscience products such as Botox Therapeutic, Vraylar, and Ubrelvy; eyecare products such as Lumigan/Ganfort, Alphagan/Combigan, and Restasis; women's health products such as Lo Loestrin and Orilissa/Oriahnn; and other key products such as Creon and Synthroid.
AbbVie SEC Filing Email Alerts Service
Open the ABBV Page at The Online Investor »
|
Open the ABBV Page at The Online Investor (in a new window) »
Free ABBV Email Alerts: Get SEC Filing Alerts Get Dividend Alerts |
Buy (3.18 out of 4) 39th percentile
(ranked lower than approx. 61% of all stocks covered)
Analysts' Target Price: ABBV Stock Forecast Based on Zacks ABR data; powered by Xignite |